Excluding fuel, sales decreased 0.5% compared to the same period last year.
Identical sales without fuel would have grown 1% in the third quarter if not for the reduction in pharmacy sales from the termination of our agreement with Express Scripts.
Third quarter operating profit was $912 million.
Adjusted EPS increased 8% compared to the same period last year. Third quarter net earnings per diluted share was $0.88.
2022